![Kathy Vincent](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Kathy Vincent currently works at TCR2 Therapeutics, Inc., as Media Contact.
Postes actifs de Kathy Vincent
Sociétés | Poste | Début |
---|---|---|
TCR2 THERAPEUTICS INC. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
TCR2 Therapeutics, Inc.
![]() TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |